CME GROUP INC (CME) is a large-cap growth stock in the Investment Services industry. The rating using this strategy is 100% based on the firm’s underlying fundamentals and the stock’s valuation.

What Happened: After conducting a thorough analysis, Carey sold 3,000 shares of CME Group. This information was disclosed in a Form 4 filing with the U.S. Securities and Exchange Commission on Monday.

EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation & Amortization): With a below-average EV/EBITDA ratio of 19.63, CME Group presents an opportunity for ...

If you buy and hold a stock for many years, you'd hope to be making a profit. Better yet, you'd like to see the ...

An in-depth analysis of recent analyst actions unveils how financial experts perceive CME Group. The following summary ... Analysts typically rate each stock once per quarter.

For investors seeking deeper insights into CME’s performance and prospects, InvestingPro offers comprehensive analysis with ... performance, CME Group’s stock experienced a decline in pre ...

Blood glucose levels in patients with diabetes are strongly correlated with the risk for cystoid macular edema and thickening ...

Fed rate cut bets and the emergence of fresh USD selling further lend support to the XAU/USD pair.

U.S. stocks finished a turbulent session higher on Wednesday after Trump administration officials said they would meet with ...

The utility of leading-edge data and analytics platforms has been a developing trend for some time. Volatile markets was the ...

EUR/USD gathered bullish momentum and rose about 0.9% on Tuesday, erasing a large portion of Monday's losses in the process.